• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部 NUT 中线癌的临床病理和分子特征。

Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.

机构信息

Department of Medical Oncology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.

Department of Pathology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

Cancer Med. 2021 Sep;10(17):5757-5764. doi: 10.1002/cam4.4096. Epub 2021 Aug 19.

DOI:10.1002/cam4.4096
PMID:34409758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8419746/
Abstract

INTRODUCTION

Pulmonary nuclear protein of the testis (NUT) midline carcinoma (NMC) is a aggressive cancer with t (15, 19) translocation. Here we present the clinicopathological characteristics and molecular genetics alterations of primary pulmonary NMC.

METHODS

Fluorescence in situ hybridization (FISH) assay was performed to evaluate NUT translocation. Next generation sequencing (NGS) was performed to investigate genomic landscape. A panel of 289 lung cancer tissues with undifferentiation was retrospectively screened for NUT expression by immunohistochemical (IHC) assay.

RESULTS

Overall, 2136 lung cancer samples were reviewed. We consecutively identified 12 cases of primary pulmonary NMC. Computed tomography revealed centrally located bulky lung mass with ipsilateral mediastinal lymph node and pleural involvements. Tumor cells presented diffuse poor differentiation and focal squamous differentiation with positive NUT expression. NUT rearrangement was confirmed by FISH assay. Ten NMC samples were investigated by NGS. The most common alterations identified were P53, PIK3CA, AUTS2, ITIH2, and CDKL5 genes. Pulmonary NMC exhibited increased activity of PI3K/AKT pathway. In the screening study, BRD4-NUT rearrangement was identified in two cases.

CONCLUSION

NUT rearrangement remains the gold standard in the diagnosis of pulmonary NMC. PI3K inhibition is a potential targeted therapy for pulmonary NMC.

摘要

简介

睾丸核蛋白(NUT)中线癌(NMC)是一种具有 t(15,19)易位的侵袭性癌症。在此,我们介绍了原发性肺 NMC 的临床病理特征和分子遗传学改变。

方法

采用荧光原位杂交(FISH)检测 NUT 易位。进行下一代测序(NGS)以研究基因组景观。通过免疫组织化学(IHC)检测对 289 例未分化的肺癌组织进行了 NUT 表达的回顾性筛选。

结果

总共回顾了 2136 例肺癌样本。我们连续确定了 12 例原发性肺 NMC。计算机断层扫描显示中央性大肺肿块伴同侧纵隔淋巴结和胸膜受累。肿瘤细胞呈弥漫性低分化和局灶性鳞状分化,NUT 表达阳性。FISH 检测证实 NUT 重排。对 10 例 NMC 样本进行了 NGS 研究。最常见的改变包括 P53、PIK3CA、AUTS2、ITIH2 和 CDKL5 基因。肺 NMC 表现出 PI3K/AKT 通路活性增加。在筛选研究中,两个病例中发现了 BRD4-NUT 重排。

结论

NUT 重排仍然是诊断肺 NMC 的金标准。PI3K 抑制是肺 NMC 的一种潜在靶向治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/487894fb3d61/CAM4-10-5757-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/62673cec997e/CAM4-10-5757-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/4913b94e42ca/CAM4-10-5757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/18eca4072d73/CAM4-10-5757-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/487894fb3d61/CAM4-10-5757-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/62673cec997e/CAM4-10-5757-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/4913b94e42ca/CAM4-10-5757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/18eca4072d73/CAM4-10-5757-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22bd/8419746/487894fb3d61/CAM4-10-5757-g004.jpg

相似文献

1
Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.肺部 NUT 中线癌的临床病理和分子特征。
Cancer Med. 2021 Sep;10(17):5757-5764. doi: 10.1002/cam4.4096. Epub 2021 Aug 19.
2
Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.原发性肺NUT中线癌:临床、影像学及病理学特征
J Thorac Oncol. 2015 Jun;10(6):951-9. doi: 10.1097/JTO.0000000000000545.
3
Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.新型 BRD4-NUT 融合异构体增加了 NUT 中线癌的发病复杂性。
Oncogene. 2013 Sep 26;32(39):4664-74. doi: 10.1038/onc.2012.487. Epub 2012 Nov 5.
4
Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.NUT 中线癌的细胞病理学特征:来自 13 名患者的 26 份标本系列。
Cancer Cytopathol. 2016 Dec;124(12):901-908. doi: 10.1002/cncy.21761. Epub 2016 Jul 11.
5
[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].[NUT基因表达及重排在诊断上呼吸道NUT中线癌中的应用]
Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):519-24. doi: 10.3760/cma.j.issn.0529-5807.2012.08.003.
6
Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.NUT 中线癌中由单一灾难性发病机制导致的复杂染色体重排。
Ann Oncol. 2017 Apr 1;28(4):890-897. doi: 10.1093/annonc/mdw686.
7
Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva.五例 NUT 中线癌的临床病理分析,包括一例发生于牙龈。
Biomed Res Int. 2020 Feb 13;2020:9791208. doi: 10.1155/2020/9791208. eCollection 2020.
8
Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.NUT重排在上呼吸道低分化恶性肿瘤中的临床病理意义
Int J Surg Pathol. 2013 Apr;21(2):102-10. doi: 10.1177/1066896912451651. Epub 2012 Jul 9.
9
NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.表达NSD3-NUT的肺中线癌:原发性癌组织的首次特征描述。
Pathol Res Pract. 2015 May;211(5):404-8. doi: 10.1016/j.prp.2014.10.013. Epub 2014 Nov 13.
10
NUT midline carcinoma of the larynx: an international series and review of the literature.喉NUT中线癌:一项国际病例系列及文献综述
Histopathology. 2017 May;70(6):861-868. doi: 10.1111/his.13143. Epub 2017 Feb 21.

引用本文的文献

1
Rapid Progression of Primary Pulmonary NUT Midline Carcinoma: A Case Report and Literature Review.原发性肺NUT中线癌的快速进展:一例报告及文献复习
Respirol Case Rep. 2025 Aug 4;13(8):e70293. doi: 10.1002/rcr2.70293. eCollection 2025 Aug.
2
Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies.肺睾丸核蛋白(NUT)癌:临床、分子特征及治疗策略
BMC Cancer. 2025 Feb 4;25(1):196. doi: 10.1186/s12885-025-13593-3.
3
Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis.

本文引用的文献

1
Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases.NUT中线癌治疗模式及预后因素对结局的影响:119例患者的系统评价与个体患者数据分析
Eur Arch Otorhinolaryngol. 2018 Mar;275(3):815-821. doi: 10.1007/s00405-018-4882-y. Epub 2018 Jan 22.
2
Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.使用经过验证的检测板对肺癌进行综合基因组分析,以探索东亚患者的治疗靶点。
Cancer Sci. 2017 Dec;108(12):2487-2494. doi: 10.1111/cas.13410. Epub 2017 Oct 20.
3
睾丸中线癌的原发性肺核蛋白:病例报告及汇总分析的系统评价
Front Oncol. 2024 Jan 9;13:1308432. doi: 10.3389/fonc.2023.1308432. eCollection 2023.
4
Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.鼻窦 NUT 癌的临床病理分子特征:两例报告及文献复习
Front Oncol. 2024 Jan 4;13:1296862. doi: 10.3389/fonc.2023.1296862. eCollection 2023.
5
NUT carcinoma of the submandibular gland: A case report.颌下腺 NUT 癌:一例报告。
Cancer Rep (Hoboken). 2023 Dec;6(12):e1900. doi: 10.1002/cnr2.1900. Epub 2023 Sep 8.
6
Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment.NUT 中线癌的长期生存和当前的治疗方法。
Oncologist. 2023 Sep 7;28(9):765-770. doi: 10.1093/oncolo/oyad177.
7
Targeted therapy for rare lung cancers: Status, challenges, and prospects.罕见肺癌的靶向治疗:现状、挑战与展望。
Mol Ther. 2023 Jul 5;31(7):1960-1978. doi: 10.1016/j.ymthe.2023.05.007. Epub 2023 May 13.
8
Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.肺 NUT 癌的临床和分子特征表现出对免疫治疗的多样化反应,其中包括一例病理完全缓解病例。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6361-6370. doi: 10.1007/s00432-023-04621-5. Epub 2023 Feb 8.
9
Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma.睾丸癌原发性肺核蛋白的临床影像学表现。
Front Med (Lausanne). 2023 Jan 4;9:1083206. doi: 10.3389/fmed.2022.1083206. eCollection 2022.
10
Multimodality imaging and treatment of paranasal sinuses nuclear protein in testis carcinoma: A case report.睾丸癌中鼻窦核蛋白的多模态成像与治疗:一例报告。
World J Clin Cases. 2022 Nov 26;10(33):12395-12403. doi: 10.12998/wjcc.v10.i33.12395.
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.
系统激酶抑制剂分析鉴定 CDK9 为 NUT 中线癌的合成致死靶点。
Cell Rep. 2017 Sep 19;20(12):2833-2845. doi: 10.1016/j.celrep.2017.08.082.
4
Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers.双组蛋白去乙酰化酶和磷脂酰肌醇-3-激酶抑制剂CUDC-907下调MYC并抑制MYC依赖性癌症的生长。
Mol Cancer Ther. 2017 Feb;16(2):285-299. doi: 10.1158/1535-7163.MCT-16-0390. Epub 2016 Dec 15.
5
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.头颈部NUT中线癌的强化治疗及生存结果
Cancer. 2016 Dec 1;122(23):3632-3640. doi: 10.1002/cncr.30242. Epub 2016 Aug 10.
6
Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.携带BRD4-NUT癌蛋白的癌肿对靶向性溴结构域抑制剂OTX015/MK-8628的临床反应
Cancer Discov. 2016 May;6(5):492-500. doi: 10.1158/2159-8290.CD-15-1335. Epub 2016 Mar 14.
7
NUT carcinoma of the thorax: Case report and review of the literature.胸部NUT癌:病例报告及文献复习
Lung Cancer. 2015 Dec;90(3):484-91. doi: 10.1016/j.lungcan.2015.10.001. Epub 2015 Oct 9.
8
Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.原发性肺NUT中线癌:临床、影像学及病理学特征
J Thorac Oncol. 2015 Jun;10(6):951-9. doi: 10.1097/JTO.0000000000000545.
9
Histone deacetylase inhibitor for NUT midline carcinoma.用于NUT中线癌的组蛋白去乙酰化酶抑制剂。
Pediatr Blood Cancer. 2015 Apr;62(4):715-7. doi: 10.1002/pbc.25350. Epub 2015 Jan 3.
10
Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.含溴结构域蛋白4(BRD4)在BRD4-NUT癌蛋白诱导的转录激活中作用的机制分析
J Biol Chem. 2015 Jan 30;290(5):2744-58. doi: 10.1074/jbc.M114.600759. Epub 2014 Dec 15.